Completed Date
Sector
Deal Type
Value
Founded in 1946, and headquartered near Bergamo, Farmol has established itself as leading Italian player in the market for the contract supply of aerosols and cosmetic liquids, detergents and medical-surgical devices. Today, the company has consolidated its position in the market and has blue chip clients who chose Farmol for its tailor-made approach and ability to identify innovative formulations.
Farmol closed 2020 with a turnover exceeding €100 million and diversified its business by entering in the healthcare sector. Farmol mostly concentrates its R&D activities in the healthcare division, with the aim to become one of the major manufacturers of aerosol solutions.
Ethica Group advised the Spanish Private Equity Portobello Capital in the acquisition of a majority stake in Farmol S.p.A., leader Contract Manufacturer in Europe in the cosmetics and household products businesses, already controlled by Green Arrow Capital.
Ethica's team acted as buy-side advisor of the transaction and advised also the acquisition financing of the operation.
The market in which Famol operates is experiencing steady growth rates both nationally and internationally, driven by decarbonization. By Leveraging on market growth and on the deep understanding of the healthcare sector, Ethica has been able to find the perfect target for Portobello Capital.
